Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2441-2446

  Franken, Romy ^a,b   Den Hartog, Alexander W ^a,b   De Waard, Vivian ^a   Engele, Leo ^a   Radonic, Teodora ^a,b   Lutter, Rene ^a   Timmermans, Janneke ^c   Scholte, Arthur J ^d   Van Den Berg, Maarten P ^e   Zwinderman, Aeilko H ^a   Groenink, Maarten ^a,b   Mulder, Barbara J M ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Aortic dissection; Aortic root growth; Biomarker; Clinical events; Marfan syndrome; Transforming growth factor beta (TGF )

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLECAINIDE; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AORTA DISSECTION; AORTA ROOT; AORTIC ROOT SURGERY; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; GROWTH CURVE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY; ADOLESCENT; AORTIC DISEASES; BLOOD; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AORTIC DISEASES; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MARFAN SYNDROME; MIDDLE AGED; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84885631183     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.033     Document Type: Article

References (35)

1. J. De Backer, B. Loeys, B. Leroy, P. Coucke, H. Dietz, and A. De Paepe Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome Clin Genet 72 3 Sep 2007 188 198
2. H.C. Dietz, G.R. Cutting, and R.E. Pyeritz Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene Nature 352 6333 Jul 25 1991 337 339
3. P. De Witte, J.J. Aalberts, and T. Radonic Intrinsic biventricular dysfunction in Marfan syndrome Heart 97 24 Dec 2011 2063 2068
4. P.M. Engelfriet, E. Boersma, J.G. Tijssen, B.J. Bouma, and B.J. Mulder Beyond the root: dilatation of the distal aorta in Marfan's syndrome Heart 92 9 Sep 2006 1238 1243
5. L.J. Meijboom, M. Groenink, E.E. van der Wall, H. Romkes, J. Stoker, and B.J. Mulder Aortic root asymmetry in marfan patients; evaluation by magnetic resonance imaging and comparison with standard echocardiography Int J Card Imaging 16 3 Jun 2000 161 168
6. L.J. Meijboom, J. Timmermans, A.H. Zwinderman, P.M. Engelfriet, and B.J. Mulder Aortic root growth in men and women with the Marfan's syndrome Am J Cardiol 96 10 Nov 15 2005 1441 1444
7. M. Groenink, T.A. Lohuis, and J.G. Tijssen Survival and complication free survival in Marfan's syndrome: implications of current guidelines Heart 82 4 Oct 1999 499 504
8. P. Engelfriet, and B. Mulder Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome? Int J Cardiol 114 3 Jan 18 2007 300 302
9. P.N. Robinson, E. Arteaga-Solis, and C. Baldock The molecular genetics of Marfan syndrome and related disorders J Med Genet 43 10 Oct 2006 769 787
10. F. Ramirez, and H.C. Dietz Marfan syndrome: from molecular pathogenesis to clinical treatment Curr Opin Genet Dev 17 3 Jun 2007 252 258
11. R.J. Akhurst, and A. Hata Targeting the TGFbeta signalling pathway in disease Nat Rev Drug Discov 11 10 Oct 2012 790 811
12. J.P. Habashi, J.J. Doyle, and T.M. Holm Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism Science 332 6027 Apr 15 2011 361 365
13. E.R. Neptune, P.A. Frischmeyer, and D.E. Arking Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 3 Mar 2003 407 411
14. C.M. Ng, A. Cheng, and L.A. Myers TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome J Clin Invest 114 11 Dec 2004 1586 1592
15. J.P. Habashi, D.P. Judge, and T.M. Holm Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science 312 5770 Apr 7 2006 117 121
16. P. Matt, F. Schoenhoff, and J. Habashi Circulating transforming growth factor-beta in Marfan syndrome Circulation 120 6 Aug 11 2009 526 532
17. T. Radonic, P. de Witte, M.J. Baars, A.H. Zwinderman, B.J. Mulder, and M. Groenink Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial Trials 11 2010 3
18. A. De Paepe, R.B. Devereux, H.C. Dietz, R.C. Hennekam, and R.E. Pyeritz Revised diagnostic criteria for the Marfan syndrome Am J Med Genet 62 4 Apr 24 1996 417 426
19. L.F. Hiratzka, G.L. Bakris, and J.A. Beckman 2010 ACCF/AHA/AATS/ACR/ASA/ SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Circulation 121 13 Apr 6 2010 e266 e369
20. A. Vahanian, O. Alfieri, and F. Andreotti Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 19 Oct 2012 2451 2496
21. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 12 Dec 2005 1440 1463
22. M.J. Roman, R.B. Devereux, R. Kramer-Fox, and J. O'Loughlin Two-dimensional echocardiographic aortic root dimensions in normal children and adults Am J Cardiol 64 8 Sep 1 1989 507 512
23. J.L. Murdoch, B.A. Walker, B.L. Halpern, J.W. Kuzma, and V.A. McKusick Life expectancy and causes of death in the Marfan syndrome N Engl J Med 286 15 Apr 13 1972 804 808
24. M. Groenink, L. Rozendaal, and M.S. Naeff Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications Heart 80 2 Aug 1998 163 169
25. M. Groenink, A. de Roos, B.J. Mulder, J.A. Spaan, and E.E. van der Wall Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome Am J Cardiol 82 2 Jul 15 1998 203 208
26. G.J. Nollen, M. Groenink, J.G. Tijssen, E.E. van der Wall, and B.J. Mulder Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome Eur Heart J 25 13 Jul 2004 1146 1152
27. D.I. Silverman, K.J. Burton, and J. Gray Life expectancy in the Marfan syndrome Am J Cardiol 75 2 Jan 15 1995 157 160
28. B.J. Mulder The distal aorta in the Marfan syndrome Neth Heart J 16 11 Nov 2008 382 386
29. L. Mimoun, D. Detaint, and D. Hamroun Dissection in Marfan syndrome: the importance of the descending aorta Eur Heart J 32 4 Feb 2011 443 449
30. T.M. Holm, J.P. Habashi, and J.J. Doyle Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice Science 332 6027 Apr 15 2011 358 361
31. D. Haskett, J.J. Doyle, and C. Gard Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome Cell Tissue Res 347 1 Jan 2012 267 277
32. P. Matt, D.L. Huso, and J. Habashi Murine model of surgically induced acute aortic dissection type A J Thorac Cardiovasc Surg 139 4 Apr 2010 1041 1047
33. Y. Mu, S.K. Gudey, and M. Landstrom Non-Smad signaling pathways Cell Tissue Res 347 1 Jan 2012 11 20
34. B.S. Brooke, J.P. Habashi, D.P. Judge, N. Patel, B. Loeys, and H.C. Dietz III Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N Engl J Med 358 26 Jun 26 2008 2787 2795
35. T. Radonic, P. de Witte, and M. Groenink Inflammation aggravates disease severity in Marfan syndrome patients PLoS One 7 3 2012 e32963